AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.315
+0.015 (0.65%)
Jul 28, 2026, 1:12 PM EDT - Market open
AC Immune Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3.7 | 3.57 | 27.31 | 14.8 | 3.94 | - | |
Revenue Growth | -86.92% | -86.92% | 84.51% | 276.14% | -74.50% | - |
Gross Profit | 3.7 | 3.57 | 27.31 | 14.8 | 3.94 | - |
Selling, General & Admin | 15.83 | 16.09 | 17.26 | 15.31 | 15.79 | 17.91 |
Research & Development | 52.26 | 56.44 | 62.57 | 54.61 | 60.34 | 62.28 |
Other Operating Expenses | 0.11 | 0.55 | 0.14 | 1.49 | 1.34 | 1.18 |
Total Operating Expenses | 68.21 | 73.08 | 79.97 | 71.4 | 77.47 | 81.37 |
Operating Income | -64.51 | -69.51 | -52.66 | -56.6 | -73.53 | -81.37 |
Interest Income | 1.41 | 1.87 | 3.2 | 1.04 | 0.07 | 6.49 |
Interest Expense | -0.2 | -0.19 | -0.13 | -0.18 | -0.36 | -0.58 |
Other Non-Operating Income (Expense) | -1.49 | -1.13 | 1.47 | -0.6 | 0.11 | 6.02 |
Total Non-Operating Income (Expense) | -0.28 | 0.55 | 4.53 | 0.27 | -0.18 | 11.92 |
Pretax Income | -66.22 | -70.45 | -50.91 | -54.22 | -70.74 | -72.99 |
Provision for Income Taxes | - | - | 0 | 0.01 | 0.01 | 0 |
Net Income | -66.22 | -70.45 | -50.92 | -54.23 | -70.75 | -73 |
Net Income to Common | -66.22 | -70.45 | -50.92 | -54.23 | -70.75 | -73 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 100 | 101 | 100 | 85 | 84 | 75 |
Shares Outstanding (Diluted) | 100 | 101 | 100 | 85 | 84 | 75 |
Shares Change | 0.13% | 1.06% | 17.71% | 1.36% | 11.48% | 4.24% |
EPS (Basic) | -0.66 | -0.70 | -0.51 | -0.64 | -0.85 | -0.97 |
EPS (Diluted) | -0.66 | -0.70 | -0.51 | -0.64 | -0.85 | -0.97 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -70.16 | 65.27 | -61.21 | -74.81 | -68.32 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | - | -0.70 | 0.65 | -0.72 | -0.90 | -0.91 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | - |
Operating Margin | -1742.44% | -1945.31% | -192.84% | -382.38% | -1868.69% | - |
Profit Margin | -1788.79% | -1971.65% | -186.44% | -366.41% | -1798.04% | - |
FCF Margin | - | -1963.67% | 238.99% | -413.55% | -1901.07% | - |
EBITDA | -64.51 | -67 | -50.5 | -54.38 | -71.17 | -78.97 |
EBITDA Margin | -1742.44% | -1875.26% | -184.92% | -367.41% | -1808.74% | - |
EBIT | -64.51 | -69.51 | -52.66 | -56.6 | -73.53 | -81.37 |
EBIT Margin | -1742.44% | -1945.31% | -192.84% | -382.38% | -1868.69% | - |
Effective Tax Rate | - | 0.00% | -0.01% | -0.02% | -0.02% | -0.00% |